Description here

Angiosarcoma

Alternative diagnostic terms
Hemangioendothelioma
Malignant Hemangioendothelioma

Common anatomical locations
More than 50% of cases arise in cutaneous sites, with the remainder occurring within deep soft tissues, breast, bone, or viscera.

Pathology comment
Angiosarcoma is characterized by vasoformative or sheet-like growth, multilayering of endothelial cells, nuclear atypia, increased mitoses, necrosis, CD31, and ERG expression by immunohistochemistry.

Source
Antonescu CR, Thway K, Billings SD. Angiosarcoma. In: WHO Classification of Tumors Editorial Board. Soft tissue and bone tumors [Internet]. Lyon (France): International Agency for Research on Cancer; 2020 [2024 Dec 29]. (WHO Classification of Tumors Series, 5th ed.; vol. 3). Available from: https://tumourclassification.iarc.who.int/login?redirecturl=%2Fchapters%2F33


For diagnosis or treatment
Any center listed in the Sarcoma Centers Directory »

Patient advocacy
Any organization with an established program for patient triage, support, and education. See Patient Support Organizations »

Diagnostic-specific organization:
Angiosarcoma Awareness

Clinical trials
SARC Clinical Trials – None
Find other clinical studies registered on ClinicalTrials.gov


Epithelioid Hemangioendothelioma (EHE)

Alternative diagnostic terms
None

Common anatomical locations
EHE most commonly involves somatic soft tissue, lung, and liver, but any site or organ can be affected.

Pathology comment
Epithelioid haemangioendothelioma is a malignant vascular neoplasm composed of epithelioid endothelial cells within a distinctive myxohyaline stroma; most cases are characterized by the presence of a WWTR1-CAMTA1 gene fusion.

Source
Antonescu CR, Rubin BP, Doyle LA, Deyrup AT. Epithelioid haemangioendothelioma. In: WHO Classification of Tumors Editorial Board. Soft tissue and bone tumors [Internet]. Lyon (France): International Agency for Research on Cancer; 2020 [2025 Jan 1]. (WHO Classification of Tumors Series, 5th ed.; vol. 3). Available from: https://tumourclassification.iarc.who.int/login?redirecturl=%2Fchapters%2F33


For diagnosis or treatment
Any center listed in the Sarcoma Centers Directory »

Patient advocacy
Any organization with an established program for patient triage, support, and education. See Patient Support Organizations »

Diagnostic-specific organizations:
The EHE Foundation
ICAN – International Cancer Advocacy Network

Clinical trials
SARC Clinical Trials – None
Find other clinical studies registered on ClinicalTrials.gov


Kaposi Sarcoma (KS)

Alternative diagnostic terms
AIDS-associated sarcoma

Common anatomical locations
Skin

Pathology comment
KS is uniformly associated with HHV8 infection, and it represents an example of virus-induced vascular proliferation.

Source
Antonescu CR, Thway K, Doyle LA, Mentzel TDW, Grayson W. Kaposi Sarcoma. In: WHO Classification of Tumors Editorial Board. Soft tissue and bone tumors [Internet]. Lyon (France): International Agency for Research on Cancer; 2020 [2024 Dec 29]. (WHO Classification of Tumors Series, 5th ed.; vol. 3). Available from: https://tumourclassification.iarc.who.int/login?redirecturl=%2Fchapters%2F33


For diagnosis or treatment
Any center listed in the Sarcoma Center Directory »

Patient advocacy
Any organization with an established program for patient triage, support, and education. See Patient Support Organizations »

Clinical trials
SARC Clinical Trials – None
Find other clinical studies registered on ClinicalTrials.gov


Intimal Sarcoma of the Pulmonary Artery

Alternative diagnostic terms
None

Common anatomical locations
Intimal sarcoma of the pulmonary circulation mainly involving the proximal vessels: the pulmonary trunk (80%), the right or left pulmonary arteries (50-70%), or both (40%).

Pathology comment
The defining feature is predominantly intraluminal growth with obstruction of the lumen of the vessel origin and seeding of emboli to peripheral organs.

Source
Fletcher CDM, Bode-Lesniewska B, Debiec-Rychter M, Tavora F. Intimal Sarcoma. In: WHO Classification of Tumors Editorial Board. Soft tissue and bone tumors [Internet]. Lyon (France): International Agency for Research on Cancer; 2020 [2024 Dec 29]. (WHO Classification of Tumors Series, 5th ed.; vol. 3). Available from: https://tumourclassification.iarc.who.int/login?redirecturl=%2Fchapters%2F33


For diagnosis or treatment
Any center listed in the Sarcoma Centers Directory »

Patient advocacy
Any organization with an established program for patient triage, support, and education. See Patient Support Organizations »

Diagnostic-specific organizations:
Angiosarcoma Awareness

Clinical trials
SARC Clinical Trials – None
Find other clinical studies registered on ClinicalTrials.gov


Hemangioendothelioma

Alternative diagnostic terms
AV Malformation Hemangioma
Low-Grade Vascular Tumors
Benign and Low-Grade Malignant Vascular Soft Tissue Tumors

Common anatomical locations
Pending

Pathology comment
Pending

Source
Pending


For diagnosis or treatment
Any center listed in the Sarcoma Centers Directory »

Patient advocacy
Any organization with an established program for patient triage, support, and education. See Patient Support Organizations »

Clinical trials
SARC Clinical Trials – None
Find other clinical studies registered on ClinicalTrials.gov


Pseudomyogenic Hemangioendothelioma

Alternative diagnostic terms
None

Common anatomical locations
Pseudomyogenic hemangioendothelioma usually arises on the lower limbs (55% of cases); the upper limbs and trunk are less commonly affected (20% each); tumors rarely occur on the head or neck (5%).

Pathology comment
Pseudomyogenic hemangioendothelioma is characterized by plump spindles or more rarely, epithelioid cell morphology with vesicular chromatin and eosinophilic cytoplasm; fascicular or sheet-like growth pattern; expression of ERG, FOSB, and keratins (AE1/AE3).

Source
Antonescu CR, Hornick JL, Bovée JVMG, Agaram NP. Pseudomyogenic haemangioendothelioma. In: WHO Classification of Tumors Editorial Board. Soft tissue and bone tumors [Internet]. Lyon (France): International Agency for Research on Cancer; 2020 [2025 Jan 1]. (WHO Classification of Tumors Series, 5th ed.; vol. 3). Available from: https://tumourclassification.iarc.who.int/login?redirecturl=%2Fchapters%2F33


For diagnosis or treatment
Any center listed in the Sarcoma Centers Directory »

Patient advocacy
Any organization with an established program for patient triage, support, and education. See Patient Support Organizations »

Clinical trials
SARC Clinical Trials – None
Find other clinical studies registered on ClinicalTrials.gov


Benign and Low-Grade Pericytic Tumors

Alternative diagnostic terms
Glomus Tumor
Myopericytoma
Myofibroma
Angioleiomyoma

Common anatomical locations
Pending

Pathology comment
Pending

Source
Pending


Back to top